NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 165 filers reported holding NEVRO CORP in Q2 2019. The put-call ratio across all filers is 5.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,211,000 | -87.6% | 67,364 | -84.1% | 0.03% | -87.5% |
| Q2 2018 | $33,890,000 | -53.0% | 424,427 | -49.0% | 0.24% | -54.3% |
| Q1 2018 | $72,091,000 | +17.7% | 831,786 | -6.3% | 0.52% | +17.2% |
| Q4 2017 | $61,266,000 | -11.5% | 887,402 | +16.5% | 0.45% | -10.2% |
| Q3 2017 | $69,230,000 | +629.5% | 761,770 | +497.4% | 0.50% | +623.2% |
| Q2 2017 | $9,490,000 | – | 127,509 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |